4//SEC Filing
Boucher Kelley 4
Accession 0001127602-25-017286
CIK 0001492422other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 4:27 PM ET
Size
6.9 KB
Accession
0001127602-25-017286
Insider Transaction Report
Form 4
Boucher Kelley
Chief People Officer
Transactions
- Award
Common Stock
2025-06-09+45,095→ 67,182 total - Award
Stock Option (Right to Buy)
2025-06-09$19.39/sh+67,396$1,306,808→ 67,396 totalExercise: $19.39Exp: 2035-06-09→ Common Stock (67,396 underlying)
Footnotes (2)
- [F1]This represents an award of Restricted Stock Units granted June 9, 2025, that vests annually from grant date over a four-year period subject to continued service.
- [F2]This represents a stock option award granted June 9, 2025 that vests over a four-year period. 25% vests one year from grant date and the remaining 75% vests monthly thereafter subject to continued service.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0002070437
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 4:27 PM ET
- Size
- 6.9 KB